Tonbul, H. Et Al. 2024. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.. Journal of drug targeting , vol.32, no.9 , 1101-1110.

Tonbul, H., Şahin, A., Öztürk, S. C., Ultav, G., Tavukçuoğlu, E., Akbaş, S., ... Aktaş, Y.(2024). An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.. Journal of drug targeting , vol.32, no.9, 1101-1110.

Tonbul, Hayrettin Et Al. "An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.," Journal of drug targeting , vol.32, no.9, 1101-1110, 2024

Tonbul, Hayrettin Et Al. "An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.." Journal of drug targeting , vol.32, no.9, pp.1101-1110, 2024

Tonbul, H. Et Al. (2024) . "An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.." Journal of drug targeting , vol.32, no.9, pp.1101-1110.

@article{article, author={Hayrettin Tonbul Et Al. }, title={An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.}, journal={Journal of drug targeting}, year=2024, pages={1101-1110} }